112 related articles for article (PubMed ID: 3460638)
1. Porphobilinogen deaminase is unstable in the absence of its substrate.
Beaumont C; Grandchamp B; Bogard M; de Verneuil H; Nordmann Y
Biochim Biophys Acta; 1986 Jul; 882(3):384-8. PubMed ID: 3460638
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of porphobilinogen deaminase, uroporphyrinogen decarboxylase, and alpha- and beta-globin mRNAs during differentiation of mouse erythroleukemic cells. Effects of succinylacetone.
Grandchamp B; Beaumont C; de Verneuil H; Nordmann Y
J Biol Chem; 1985 Aug; 260(17):9630-5. PubMed ID: 3860503
[TBL] [Abstract][Full Text] [Related]
3. Effects of succinylacetone on dimethylsulfoxide-mediated induction of heme pathway enzymes in mouse friend virus-transformed erythroleukemia cells.
Beaumont C; Deybach JC; Grandchamp B; da Silva V; de Verneuil H; Nordmann Y
Exp Cell Res; 1984 Oct; 154(2):474-84. PubMed ID: 6592100
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of porphobilinogen deaminase. The participation of stable enzyme substrate covalent intermediates between porphobilinogen and the porphobilinogen deaminase from Rhodopseudomonas spheroides.
Jordan PM; Berry A
Biochem J; 1981 Apr; 195(1):177-81. PubMed ID: 6975621
[TBL] [Abstract][Full Text] [Related]
5. Induction of delta-aminolevulinic acid dehydratase in mouse Friend virus-transformed erythroleukemia cells during erythroid differentiation.
Chang CS; Sassa S
Blood; 1984 Jul; 64(1):64-70. PubMed ID: 6587918
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of apo-porphobilinogen deaminase: structural changes induced by cofactor binding.
Scott AI; Clemens KR; Stolowich NJ; Santander PJ; Gonzalez MD; Roessner CA
FEBS Lett; 1989 Jan; 242(2):319-24. PubMed ID: 2644132
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the pyrromethane cofactor of hydroxymethylbilane synthase (porphobilinogen deaminase) is bound through the sulphur atom of a cysteine residue.
Hart GJ; Miller AD; Battersby AR
Biochem J; 1988 Jun; 252(3):909-12. PubMed ID: 3421931
[TBL] [Abstract][Full Text] [Related]
8. Evidence that the pyrromethane cofactor of hydroxymethylbilane synthase (porphobilinogen deaminase) is bound to the protein through the sulphur atom of cysteine-242.
Miller AD; Hart GJ; Packman LC; Battersby AR
Biochem J; 1988 Sep; 254(3):915-8. PubMed ID: 3196304
[TBL] [Abstract][Full Text] [Related]
9. Purification of porphobilinogen deaminase from Euglena gracilis and studies of its kinetics.
Williams DC; Morgan GS; McDonald E; Battersby AR
Biochem J; 1981 Jan; 193(1):301-10. PubMed ID: 6796041
[TBL] [Abstract][Full Text] [Related]
10. Investigation into the nature of substrate binding to the dipyrromethane cofactor of Escherichia coli porphobilinogen deaminase.
Warren MJ; Jordan PM
Biochemistry; 1988 Dec; 27(25):9020-30. PubMed ID: 3069132
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis of uroporphyrinogens from porphobilinogen: mechanism and the nature of the process.
Frydman B; Frydman RB; Valasinas A; Levy ES; Feinstein G
Philos Trans R Soc Lond B Biol Sci; 1976 Feb; 273(924):137-60. PubMed ID: 4834
[TBL] [Abstract][Full Text] [Related]
12. Determination of erythrocyte hydroxymethylbilane synthase activity and its application for study of acute intermittent porphyria.
Lee FY; Hsiao KJ; Tsai YT; Lee SD; Wu SJ; Jeng HS
Taiwan Yi Xue Hui Za Zhi; 1988 Nov; 87(11):1029-35. PubMed ID: 3235962
[No Abstract] [Full Text] [Related]
13. Evidence for a dipyrromethane cofactor at the catalytic site of E. coli porphobilinogen deaminase.
Jordan PM; Warren MJ
FEBS Lett; 1987 Dec; 225(1-2):87-92. PubMed ID: 3079571
[TBL] [Abstract][Full Text] [Related]
14. Availability of porphobilinogen controls appearance of porphobilinogen deaminase activity in Escherichia coli K-12.
Umanoff H; Russell CS; Cosloy SD
J Bacteriol; 1988 Oct; 170(10):4969-71. PubMed ID: 3049558
[TBL] [Abstract][Full Text] [Related]
15. Identification of a cysteine residue as the binding site for the dipyrromethane cofactor at the active site of Escherichia coli porphobilinogen deaminase.
Jordan PM; Warren MJ; Williams HJ; Stolowich NJ; Roessner CA; Grant SK; Scott AI
FEBS Lett; 1988 Aug; 235(1-2):189-93. PubMed ID: 3042456
[TBL] [Abstract][Full Text] [Related]
16. Molecular forms of porphobilinogen deaminase in acute intermittent porphyria. A study by Western immunoblotting.
Nunn AV; Gardner LC; Cox TM
Q J Med; 1987 Jul; 64(243):589-99. PubMed ID: 3671663
[TBL] [Abstract][Full Text] [Related]
17. Sequential induction of heme pathway enzymes during erythroid differentiation of mouse Friend leukemia virus-infected cells.
Sassa S
J Exp Med; 1976 Feb; 143(2):305-15. PubMed ID: 1249519
[TBL] [Abstract][Full Text] [Related]
18. Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion.
Sardh E; Rejkjaer L; Andersson DE; Harper P
Clin Pharmacokinet; 2007; 46(4):335-49. PubMed ID: 17375984
[TBL] [Abstract][Full Text] [Related]
19. Acute intermittent porphyria: characterization of a novel mutation in the structural gene for porphobilinogen deaminase. Demonstration of noncatalytic enzyme intermediates stabilized by bound substrate.
Desnick RJ; Ostasiewicz LT; Tishler PA; Mustajoki P
J Clin Invest; 1985 Aug; 76(2):865-74. PubMed ID: 3897290
[TBL] [Abstract][Full Text] [Related]
20. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria.
Kostrzewska E; Gregor A
Ann Clin Res; 1986; 18(4):195-8. PubMed ID: 3789651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
